About this Site


Information about Harvard University’s connection to Massachusetts venture-backed companies is based on an analysis of venture capital investment data purchased from CB Insights, and on information obtained from publicly available websites. All connections between Harvard and the funded companies, and Harvard and venture capital firms, reflect the point in time when the connections were mapped.

Two types of “connections” are highlighted on this site: connections to Harvard University and connections to the affiliated teaching hospitals. A connection to Harvard is defined as a faculty member, staff member, alumnus, or student who holds a management or advisory role at a venture capital firm or funded company. For a connection to an affiliated teaching hospital to exist, three relationships must be present – an individual must be a member of the Harvard community, must hold a management or advisory role at a venture capital firm or funded company, and must have an appointment at an affiliated teaching hospital.

Beyond the Biotech Sector

The industries highlighted in this section have been selected based on CB Insights’ classification of funded companies. The following chart provides yearly data on the number of venture-funded companies that can be linked to Harvard, followed by the total number of companies that received funding.

  2011 2012 2013 2014 2015
Agriculture 1/1 1/1 0/1 0/1 1/1
Automotive and Transportation 0/2 0/2 1/4 2/5 0/1
Business Products 0/2 0/0 0/0 0/0 0/0
Business Products and Services 4/4 3/4 1/3 2/2 2/3
Computer Hardware and Services 4/11 1/8 7/16 7/13 9/13
Consumer Products and Services 1/1 3/5 2/4 7/11 9/12
Electronics 1/4 4/7 3/6 3/7 4/8
Energy and Utilities 3/13 7/13 6/7 6/7 6/8
Environmental Services and Equipment 1/1 0/1 0/0 0/0 0/0
Financial 1/1 3/3 1/1 1/1 0/0
Food and Beverage 0/2 1/2 1/2 0/2 1/1
Healthcare 84/109 71/79 69/84 83/91 85/95
Industrial 6/12 5/10 8/10 6/9 6/8
Internet 35/65 57/91 67/102 67/123 76/108
Leisure 1/1 0/0 0/0 0/0 1/1
Mobile and Telecommunications 7/18 10/24 15/28 15/45 22/43
Retail (non-internet/mobile) 0/0 0/0 0/0 0/1 0/0
Risk and Security 0/1 0/2 0/0 1/2 0/1
Software (non-internet/mobile) 8/19 11/22 10/16 12/21 18/18

Ecosystem at Work (2011-2015)

Between 2011 and 2015, 95 Massachusetts biotech companies with a connection to Harvard received venture capital funding. These companies received 94.3 percent – a total of $3.3B – of all biotech venture capital fund awarded to Massachusetts companies. Among the companies that received venture capital awards are established companies with products in the late stages of clinical trials and young companies still testing the commercial viability of an idea.

If a company is missing from the list below that you believe should be included, please email community@harvard.edu and a member of the project team will be in touch.

A complete alphabetical list of the ninety-five Harvard connected biotech companies follows:

480 Biomedical Watertown, MA

Acceleron Pharma Cambridge, MA
Acetylon Pharmaceuticals Boston, MA
Agios Pharmaceuticals Cambridge, MA
Alcyone Lifesciences Concord, MA
Allena Pharmaceuticals Newton, MA
AlloCure Burlington, MA
Annovation BioPharma Wayland, MA
Arteaus Therapeutics Cambridge, MA
Ataxion Cambridge, MA
Avaxia Biologics Lexington, MA

BIND Biosciences Cambridge, MA
Blend Therapeutics Watertown, MA
Bluebird Bio Cambridge, MA
Blueprints Medicine Cambridge, MA

Catabasis Pharmaceuticals Cambridge, MA
Cerulean Pharma Cambridge, MA
Codiak Biosciences Cambridge, MA
Constellation Pharmaceuticals Cambridge, MA
CoStim Pharmaceuticals Boston, MA

Decimmune Therapeutics Cambridge, MA
Dekkun (changed its name to HealthCare Pharmaceuticals) Cambridge, MA
Dimension Therapeutics Cambridge, MA

Editas Medicine Cambridge, MA
Eleven Biotherapeutics Cambridge, MA
Emulate Cambridge, MA
enEvolv Cambridge, MA
Euthymics Bioscience Cambridge, MA
Evelo Therapeutics Cambridge, MA
Excelimmune Cambridge, MA
EyeGate Pharma Waltham, MA

Gelesis Boston, MA
Genocea Biosciences Cambridge, MA
Ginko BioWorks Boston, MA
GITR Cambridge, MA
GliaCure Boston, MA

Histogenics Waltham, MA

ImmuneXcite Lexington, MA
Immusan T Cambridge, MA
Intellia Therapeutics Cambridge, MA

Kala Pharmaceuticals Waltham, MA

Lysosomal Therapeutics Cambridge, MA

Macrolide Pharmaceuticals Newton Lower Falls, MA
Mersana Therapeutics Cambridge, MA
Merrimack Pharmaceuticals Cambridge, MA
Moderna   Cambridge, MA

NeuroPhage Pharmaceuticals Cambridge, MA
Nimbus Discovery Cambridge, MA
Nuclea Biotechnologies Pittsfield, MA

Opsonix Cambridge, MA
ORIG3N Boston, MA

Potenza Therapeutics Cambridge, MA
Prexa Pharmaceuticals Boston, MA
Pulmatrix Lexington, MA

Quad Technologies Woburn, MA
Quartet Medicine Cambridge, MA

Ra Pharmaceuticals Cambridge, MA
Radius Health Cambridge, MA
RaNA Therapeutics Cambridge, MA
Rhythm Metabolic Boston, MA
Rhythm Pharmaceuticals Boston, MA
Ribon Therapeutics Wellesley Hills, MA

Sabik Medical Sudbury, MA
Sample6 Technologies Boston, MA
Satori Pharmaceuticals Cambridge, MA
Semma Therapeutics Cambridge, MA
Sentien Biotechnologies Medford, MA
SeqLL Woburn, MA
Sialix (changed its name to Siamab Therapeutics) Waban, MA
Spero Therapeutics Cambridge, MA
SpringLeaf Therapeutics Boston, MA
Stromedix Cambridge, MA
Surface Oncology Cambridge, MA
Symbiota Cambridge, MA
Synageva BioPharma Lexington, MA
Synchroneuron Inc. Waltham, MA
Syndexa Pharmaceuticals Watertown, MA
Synlogic Cambridge, MA
Syros Pharmaceuticals Watertown, MA

TARIS Biomedical Lexington, MA
TESARO Waltham, MA
Tokai Pharmaceuticals Cambridge, MA
Topokine Therapeutics Newton Center, MA
Torque Therapeutics Cambridge, MA

Ultivue Cambridge, MA
Unum Therapeutics Cambridge, MA

Vedantra Pharmaceuticals Cambridge, MA
Verastem Cambridge, MA
Visterra Cambridge, MA
Voyager Therapeutics Cambridge, MA

Warp Drive Bio Cambridge, MA

X4 Pharmaceuticals Cambridge, MA
X-BODY Biosciences Waltham, MA
XTuit Pharmaceuticals Waltham, MA

Zafgen Boston, MA